Ultra-low contrast coronary angiography and zero-contrast percutaneous coronary intervention for prevention of contrast-induced nephropathy: step-by-step approach and review

atorvastatin and prevention of contrast induced nephropathy following coronary angiography

background: contrast induced nephropathy (cin) is one of the most common complications after radiographic procedures using intravascular radiocontrast media. the aim of the current study was to assess the effect of atorvastatin on prevention of cin in patients undergoing coronary angiography. materials and methods: in a clinical trial study, 200 patients referred for angiography were randomly d...

Coronary Angiography and Contrast-Induced Nephropathy

Atorvastatin and prevention of contrast induced nephropathy following coronary angiography

BACKGROUND Contrast induced nephropathy (CIN) is one of the most common complications after radiographic procedures using intravascular radiocontrast media. The aim of the current study was to assess the effect of atorvastatin on prevention of CIN in patients undergoing coronary angiography. MATERIALS AND METHODS In a clinical trial study, 200 patients referred for angiography were randomly d...

Contrast-Induced Nephropathy in Coronary Angiography and Intervention

Contrast-induced nephropathy: the sin of primary percutaneous coronary intervention?

Contrast-induced nephropathy (CIN) also described at acute kidney injury (AKI) is an acute renal failure occurring within the days after exposure to intravascular radiographic contrast material that is not attributable to other causes. It is the third most common cause of hospital-acquired renal failure, after decreased renal perfusion and use of nephrotoxic medications. More than 70 years afte...